Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) reported Q3 EPS of ($0.48), $0.03 better than the analyst estimate of ($0.51).

For earnings history and earnings-related data on Olema Pharmaceuticals, Inc. (OLMA) click here.